Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs RMD✓SelectedUSD · RMDGSK vs RMD performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs RMD

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+102.1%
RMD return
+358.7%
Excess return
-256.6%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioRMDExcessAlpha
1D-1.3%+2.0%-3.3%-1.8%
7D-3.1%+2.0%-5.1%-3.5%
30D-0.9%+1.5%-2.4%-1.4%
3M-4.2%+10.9%-15.1%-6.4%
6M-1.6%+19.5%-21.1%-5.6%
YTD+2.6%+1.8%+0.8%+1.5%
1Y+6.2%-0.4%+6.6%+5.6%
3Y+55.0%+67.7%-12.7%+36.4%
5Y+42.8%-3.4%+46.2%+38.8%
10Y+102.1%+361.7%-259.6%+53.6%
All+102.1%+358.7%-256.6%+53.6%

Cumulative growth

Daily Returns

Daily percentage return beside RMD.

Daily Out/Under-Performance

Portfolio return minus RMD return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × RMD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded RMD wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling